Source-grounded facts extracted from Axe Compute Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
J. Melville Engle departed as Chief Executive Officer and Chairman at Axe Compute Inc..
“J. Melville Engle would be retiring as the Company’s Chief Executive Officer and as Chairman and a member of the Company’s board of directors, effective October 31, 2022.”
J. Melville Engle departed as Chief Executive Officer at Axe Compute Inc..
“On September 15, 2022, J. Melville Engle announced that he will retire as the Chief Executive Officer of Predictive Oncology Inc. (the “Company”) and as Chairman and a member of the Company’s board of directors, effective October 31, 2022.”
Julia Kirshner was appointed as Chief Scientific Officer at Axe Compute Inc..
“On July 26, 2022 the Company announced that Julia Kirshner, Ph.D., has been appointed Chief Scientific Officer of the Company, effective August 1, 2022.”
Christina Jenkins resigned as director at Axe Compute Inc..
“On May 18, 2022, Christina Jenkins, M.D. notified Predictive Oncology® Inc. (the “Company”) that she intends to resign as a director of the Company, effective August 31, 2022, in order to devote more time to her other business interests.”
Raymond F. Vennare was elected as Director at Axe Compute Inc..
“Effective September 13, 2021, the Board of Directors (“Board”) of Predictive Oncology Inc. (the “Company”) elected Raymond F. Vennare to the Board.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.